Jump to content

Search the Community

Showing results for tags 'covid-19'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Categories

  • Articles
    • Forum Integration
    • Frontpage
  • Pages
  • Miscellaneous
    • Databases
    • Templates
    • Media

Forums

  • Cars
    • General Car Discussion
    • Tips and Resources
  • Aftermarket
    • Accessories
    • Performance and Tuning
    • Cosmetics
    • Maintenance & Repairs
    • Detailing
    • Tyres and Rims
    • In-Car-Entertainment
  • Car Brands
    • Japanese Talk
    • Conti Talk
    • Korean Talk
    • American Talk
    • Malaysian Talk
    • China Talk
  • General
    • Electric Cars
    • Motorsports
    • Meetups
    • Complaints
  • Sponsors
  • Non-Car Related
    • Lite & EZ
    • Makan Corner
    • Travel & Road Trips
    • Football Channel
    • Property Buzz
    • Investment & Financial Matters
  • MCF Forum Related
    • Official Announcements
    • Feedback & Suggestions
    • FAQ & Help
    • Testing

Blogs

  • MyAutoBlog

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


  1. Source: https://mustsharenews.com/free-art-kits/ 10 Free ART Kits Arriving In Letterboxes Via SingPost, Will Help In Self-Testing As Covid-19 cases surge in Singapore once again, the Government is taking measures to mitigate the spread somewhat. One of them is by ensuring that citizens test themselves to detect infection early. To that end, 10 free Antigen Rapid Test (ART) kits will be distributed via post from next Monday (18 Jul). However, some households may need to wait a few weeks to get theirs. 10 free ART kits for every household In a Facebook post on Friday (15 Jul), the Ministry of Health (MOH) said the 10 free ART kits will be given to every Singapore household. They will be delivered by SingPost. All residential addresses in Singapore are eligible for them, they added in an FAQ on the MOH website. Those who live in HDB flats and condominiums, which make up the majority, will receive the kits in their letterboxes. Residents of landed properties will get them delivered to their doorsteps. Some households may wait a few weeks Many Singaporeans might be understandably eager to get the free ART kits so they wouldn’t have to rush to a pharmacy to buy them when they’re sick. However, some households might have to wait “a few weeks” for the deliveries. That’s because of the high volume of kits that are being distributed, MOH said. They sought the patience of citizens for the possible delay in getting the stock. Free ART kits encourage regular self-testing The free ART kits were promised by Deputy Prime Minister Lawrence Wong in June as he spoke about the recent wave. Then, he urged everyone to test themselves regularly for Covid-19 if possible. This is especially if you’re feeling unwell, or going to visit vulnerable family members and friends. The distribution of free ART kits is thus a way to encourage people to self-test often. In this way, we can practise social responsibility by taking precautions to protect others. More ART kits can be requested For households with many members, 10 ART kits might not be enough. Thus, MOH strongly encouraged households to purchase more if need be. However, lower-income households will continue to receive help — they can request for additional ART kits. These households should be beneficiaries of Social Service Offices (SSOs) and Family Service Centres (FSCs). They can get their kits from these places, MOH added. The Early Childhood Development Agency (ECDA) will also provide ART kits to children from lower-income households, upon request. Encouraging a self-testing culture As the various variants of Omicron rear their ugly heads in Singapore, we’re sure citizens will appreciate the free ART kits. Hopefully, this will ensure all residents have sufficient kits and encourage regular testing to reduce the likelihood of spreading the virus. If we all behave responsibly, we can ride this wave together and emerge stronger at the other end like we’ve done before.
  2. Oh no Boris is in trouble! He is on the verge of being kicked out as PM Let us help him!
  3. come back to office or else f off ....
  4. https://www.todayonline.com/singapore/public-servants-receive-notification-election-duties-and-online-training-1868266 Notification / trainings issued!🤣 Beat metal while it is hot!😁 Covid well done???🥳🥳
  5. I read from somewhere that Moderators need to clock post? Here's me playing my part to clock MCF posts. But please ah, only MCF mods are entitled to start a #IAMCOVIDPOSITIVE too thread. #19FebDay1
  6. Valneva says early studies show COVID-19 vaccine effective against Omicron Jan 19 (Reuters) - French biotech firm Valneva (VLS.PA) said on Wednesday that preliminary studies showed that three doses of its inactivated COVID-19 vaccine candidate neutralised the Omicron variant of the disease. All of the serum samples tested presented neutralizing antibodies against the ancestral virus and Delta variant, it said, while 87% of samples did so against the Omicron variant. "We are extremely pleased with these results," said Chief Medical Officer Juan Carlos Jaramillo in a statement, noting that these added to an earlier Phase III trial that showed improved immune response with two doses of the VLA2001 candidate. Valneva expects to receive potential approvals for its vaccine within the first three months of 2022, and is providing data to the European Medicines Agency (EMA) as well as regulators in the UK and Bahrain.
  7. https://www.channelnewsasia.com/asia/hong-kong-orders-hamster-cull-after-covid-19-hits-pets-2442871 The outbreak of Delta variant cases in humans linked to the shop worker prompted tests on hundreds of animals, with 11 hamsters showing up positive. That has brought a pet rodent clampdown on Chinese-ruled Hong Kong, which is following the mainland's zero-tolerance approach to COVID-19 even as much of the world shifts to living with it. The territory's Health Secretary Sophia Chan stressed at a news conference that there was no evidence domestic animals can pass the disease to humans, but authorities were anyway acting out of caution to ban imports and sales of pet rodents. Still living in the shadows of COVID-19, are we? Maybe we should start culling humans since we are the ones transmitting the virus. RIP my furry friends! Insert two cute hamsters below. ☹️
  8. With a high efficacy close to mRNA, it should be good news to poorer countries. Texas scientists’ new Covid-19 vaccine is cheaper, easier to make and patent-free Dr Maria Bottazzi says their vaccine, called Corbevax, is unique because they do not intend to patent it Erum Salam Sat 15 Jan 2022 10.00 GMT A new Covid-19 vaccine is being developed by Texas scientists using a decades-old conventional method that will make the production and distribution cheaper and more accessible for countries most affected by the pandemic and where new variants are likely to originate due to low inoculation rates. The team, led by Drs Peter Hotez and Maria Bottazzi from the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine, has been developing vaccine prototypes for Sars and Mers since 2011, which they reconstructed to create the new Covid vaccine, dubbed Corbevax, or “the world’s Covid-19 vaccine”. Although more than 60 other vaccines are in development using the same technology, Bottazzi said their vaccine is unique because they do not intend to patent it, allowing anyone with the capacity to reproduce it. “Pretty much anybody that can make hepatitis B vaccines or has the capacity to produce microbial-based protein like bacteria or yeast, can replicate what we do,” Bottazzi said. Patent wars over mRNA vaccines have recently heated up. Moderna and the National Institutes of Health are in a dispute over who should get credit for specific discoveries that led to a Covid-19 vaccine which has been delivered to more than 73 million Americans. If Moderna is found to have infringed on the federal government’s patent, it could be forced to pay more than $1bn. At the same time, activists have called for Pfizer and Moderna to share the technology and knowhow for producing their vaccines, including taking the fight to the World Trade Organization. Low-income countries, which have few vaccine research and production facilities, have vaccinated just one in nine people, according to the World Health Organization. The US has fully vaccinated 67% of the population and provided a third vaccine dose to more than one-third. Corbevax’s clinical trial data has yet to be released due to resource constraints, but Texas Children’s hospital said the vaccine was over 90% effective against the original Covid-19 strain and over 80% effective against the Delta variant. The vaccine’s efficacy against the Omicron variant is currently being tested. The process to create the vaccine involves the use of yeast – the same method by which hepatitis B vaccines are produced. The Moderna, Pfizer and Johnson & Johnson vaccines currently authorized in the US use different technologies, or vaccine “platforms”. Moderna and Pfizer use messenger RNA (mRNA) technology. This platform introduces the immune system to Covid-19 by delivering instructions on how to produce its most recognizable feature, the spike proteins which coat its surface. This helps the immune system recognize and fight the virus later, if a person is exposed. Johnson & Johnson’s vaccine introduces immune cells to the spike protein through an otherwise harmless cold virus, a technology called viral vector. The Corbevax vaccine uses a platform called recombinant protein sub-unit technology, which places an actual piece of Covid-19’s spike protein in yeast cells. The yeast cells then copy the vital protein and the protein is introduced to the immune system. “We make the protein, directly and synthetically, in the lab using the yeast system,” Bottazzi explained. “We ask the yeast to make a protein that looks just like a protein that is made by the virus. Then we immunize the protein and the body then processes this protein and presents it to the immune system. Therefore, you don’t ask your body to do any major manipulation of the coding.” Crucially, storing the Corbevax vaccine only requires standard refrigeration, unlike the Pfizer vaccine, which requires ultra-cold storage in transit. Biological E, an Indian pharmaceutical company accustomed to producing hepatitis B vaccines with whom Bottazzi’s team has a longstanding relationship, has already produced 150m doses of the new Corbevax vaccine and will soon be able to produce 100m doses every month. After being overlooked by government organizations for funding, Bottazzi said, the developers behind Corbevax relied on philanthropic donations to get them over the finish line. The Texas Children’s Hospital Center for Vaccine Development is an academic and scientific institution in nature, but Bottazzi said developing Corbevax had forced them to stretch their resources in order to gain visibility as a serious candidate for Covid vaccine development. “We ourselves are learning how to do work that is regulatory-enabling, that enables good quality, good reproduction, good record-keeping … we mimic as if we were a small biotech or manufacturing entity,” she said. “Every technology has pros and cons. Nobody is claiming one is the super-duper, only solution. All the [vaccines] are part of the solution. But when you have a situation of such gravity around the world, you don’t pick and choose a solution – you try to use all solutions,” Bottazzi said. Bottazzi said the reason she and her team did not patent the vaccine was because of her team’s shared philosophy of humanitarianism and to engage in collaboration with the wider scientific community. “We want to do good in the world. This was the right thing to do and this is what we morally had to do. We didn’t even blink. We didn’t think, ‘how can we take advantage of this?’ You see now that if more like us would have been more attuned to how the world is so inequitable and how we could have helped from the beginning so many places around the world without thinking ‘what’s going to be in it for me?’, we could have basically not even seen these variants arise.” Bottazzi hopes her move will incentivize others to follow suit and make affordable and accessible vaccines for other diseases and viruses, like hookworm. “We need to break these paradigms that it’s only driven by economic impact factors or return of economic investment. We have to look at the return in public health.”
  9. Update on Omicron. https://www.who.int/news/item/28-11-2021-update-on-omicron On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a summary of what is currently known. Current knowledge about Omicron Researchers in South Africa and around the world are conducting studies to better understand many aspects of Omicron and will continue to share the findings of these studies as they become available. Transmissibility: It is not yet clear whether Omicron is more transmissible (e.g., more easily spread from person to person) compared to other variants, including Delta. The number of people testing positive has risen in areas of South Africa affected by this variant, but epidemiologic studies are underway to understand if it is because of Omicron or other factors. Severity of disease: It is not yet clear whether infection with Omicron causes more severe disease compared to infections with other variants, including Delta. Preliminary data suggests that there are increasing rates of hospitalization in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron. There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants. Initial reported infections were among university students—younger individuals who tend to have more mild disease—but understanding the level of severity of the Omicron variant will take days to several weeks. All variants of COVID-19, including the Delta variant that is dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key. Effectiveness of prior SARS-CoV-2 infection Preliminary evidence suggests there may be an increased risk of reinfection with Omicron (ie, people who have previously had COVID-19 could become reinfected more easily with Omicron), as compared to other variants of concern, but information is limited. More information on this will become available in the coming days and weeks. Effectiveness of vaccines: WHO is working with technical partners to understand the potential impact of this variant on our existing countermeasures, including vaccines. Vaccines remain critical to reducing severe disease and death, including against the dominant circulating variant, Delta. Current vaccines remain effective against severe disease and death. Effectiveness of current tests: The widely used PCR tests continue to detect infection, including infection with Omicron, as we have seen with other variants as well. Studies are ongoing to determine whether there is any impact on other types of tests, including rapid antigen detection tests. Effectiveness of current treatments: Corticosteroids and IL6 Receptor Blockers will still be effective for managing patients with severe COVID-19. Other treatments will be assessed to see if they are still as effective given the changes to parts of the virus in the Omicron variant. Studies underway At the present time, WHO is coordinating with a large number of researchers around the world to better understand Omicron. Studies currently underway or underway shortly include assessments of transmissibility, severity of infection (including symptoms), performance of vaccines and diagnostic tests, and effectiveness of treatments. WHO encourages countries to contribute the collection and sharing of hospitalized patient data through the WHO COVID-19 Clinical Data Platform to rapidly describe clinical characteristics and patient outcomes. More information will emerge in the coming days and weeks. WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus. Recommended actions for countries As Omicron has been designated a Variant of Concern, there are several actions WHO recommends countries to undertake, including enhancing surveillance and sequencing of cases; sharing genome sequences on publicly available databases, such as GISAID; reporting initial cases or clusters to WHO; performing field investigations and laboratory assessments to better understand if Omicron has different transmission or disease characteristics, or impacts effectiveness of vaccines, therapeutics, diagnostics or public health and social measures. More detail in the announcement from 26 November. Countries should continue to implement the effective public health measures to reduce COVID-19 circulation overall, using a risk analysis and science-based approach. They should increase some public health and medical capacities to manage an increase in cases. WHO is providing countries with support and guidance for both readiness and response. In addition, it is vitally important that inequities in access to COVID-19 vaccines are urgently addressed to ensure that vulnerable groups everywhere, including health workers and older persons, receive their first and second doses, alongside equitable access to treatment and diagnostics. Recommended actions for people The most effective steps individuals can take to reduce the spread of the COVID-19 virus is to keep a physical distance of at least 1 metre from others; wear a well-fitting mask; open windows to improve ventilation; avoid poorly ventilated or crowded spaces; keep hands clean; cough or sneeze into a bent elbow or tissue; and get vaccinated when it’s their turn. WHO will continue to provide updates as more information becomes available, including following meetings of the TAG-VE. In addition, information will be available on WHO’s digital and social media platforms.
  10. Boom and doom? Singapore to launch vaccinated travel lanes with India, Indonesia and Saudi Arabia SINGAPORE: Singapore will extend its vaccinated travel lane (VTL) scheme to more countries starting from Nov 29, according to the Ministry of Health (MOH) on Monday (Nov 15). The country intends to launch VTLs with India and Indonesia from Nov 29, and with Qatar, Saudi Arabia and the United Arab Emirates (UAE) from Dec 6.
  11. Pfizer says its experimental pill reduces risk of hospitalization, death from Covid-19 By Maggie Fox, and Amanda Sealy, CNN Updated 1045 GMT (1845 HKT) November 5, 2021 (CNN)Drugmaker Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug. The company hopes it can eventually offer the pill, given in combination with an older antiviral drug called ritonavir, to people to take at home before they get sick enough to go to the hospital. A so-called interim analysis -- done before the trial was scheduled to end -- showed an 89% reduction in the risk of hospitalization or death from Covid-19 if patients got it soon enough, the company said. Pfizer released the results in a news release and did not provide scientists to discuss the data ahead of release. The data has not been peer reviewed or published. The company says it will share more specifics in a peer-reviewed paper and with its submission to the US Food and Drug Administration. The company has been testing the drug in adults with Covid-19 who are considered at high risk of progressing to severe illness. The volunteers have been randomly given either the pill combination or a placebo within three days or five days of their symptoms starting. The pill, still known by its experimental name PF-07321332, is what's known as a protease inhibitor. It's designed to stop the virus from multiplying. Giving it along with ritonavir slows its breakdown in the body, the company said. Pfizer said 0.8% of patients who got the drug combination within three days were hospitalized within four weeks -- three out of 389 patients -- compared to 7% of patients who got placebos, or 27 out of 385. And seven of those who got placebos died, Pfizer said. No one who got the treatment died within a month. "Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset; 1% of patients who received PF-07321332 (with) ritonavir were hospitalized through Day 28 following randomization (6/607 hospitalized, with no deaths), compared to 6.7% of patients who received a placebo," the company said. It said 19% of patients given the treatment suffered adverse events, compared to 21% who got placebo, but declined to disclose what those adverse events were. "These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients' lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations," Albert Bourla, chairman CEO of Pfizer, said in a statement. Currently, remdesivir, sold under the brand name Veklury, is the only antiviral approved by FDA for treatment of Covid-19. It's given by intravenous infusion, so it's not as simple to administer as a pill. People can also be treated with monoclonal antibodies, which are injected or infused therapies that kickstart the immune system to help fight off infection. They are not as easy to take as a pill and must be administered by a trained professional. Merck is seeking FDA emergency use authorization for molnupiravir, an antiviral capsule people could take at home. It's been shown to reduce the risk of hospitalization or death by about 50%. On Thursday, UK drug regulators authorized molnupiravir under the brand name Lagevrio.
  12. If You Got Pfizer, You May Not Have Antibodies Against Delta After This Long (yahoo.com) https://www.yahoo.com/lifestyle/got-pfizer-may-not-antibodies-103253108.html Durability of immune responses to the BNT162b2 mRNA vaccine | bioRxiv https://www.biorxiv.org/content/10.1101/2021.09.30.462488v1 That means Pfizer vaccines T cell response to Covid19 also wane to below detectable level. Pfizer/mRNA is like "useless". Look at all the daily new cases here almost all had already been vaccinated with 2 doses of Pfizer. And Pfizer doesn't prevent you from death if kena Covid-19 as daily updates shown
  13. MOH has came out to clarified whether true or not, the post sounds politically motivated lets sit back watch show in the meantime pls refrain from spreading unverified news later tio pofma
  14. Book a Toyota now and walk away with $560 worth of petrol vouchers if you're fully vaccinated! 😆 https://www.sgcarmart.com/new_cars/newcars_adpage.php?Make=Toyota
  15. Saw this post but now it was taken down.
  16. If you have fifteen minutes to spare. This is quite harrowing to listen. 😥
  17. What's Allowed From June 14 & What's Allowed From June 21? Everything You Need To Know About Phase 3 (HA) https://www.todayonline.com/8days/seeanddo/thingstodo/whats-allowed-june-14-whats-allowed-june-21-everything-you-need-know-about P3HA wef June 14e.
  18. COVID-19 antigen rapid test (ART) kits for self-testing will be "sold by pharmacists" to the public from Jun 16, said the Ministry of Health (MOH) on Thursday (Jun 10). These self-test kits have received interim authorisation from the Health Sciences Authority (HSA) to be sold to the general public. The kits are: Abbott PanBio COVID-19 Antigen Self-test, QuickVue At-Home OTC COVID-19 Test, SD Biosensor SARS-CoV-2 Antigen Self-Test Nasal, and SD Biosensor Standard Q COVID-19 Ag Home Test. These tests produce results in less than 20 minutes, said the Health Ministry. "They are simple to use, they can be self administered. From next week, Jun 16, these kits will be dispensed by pharmacists at selected retail pharmacies. We will then open up for counter sales at more retail locations progressively," said Health Minister Ong Ye Kung at a multi-ministry task force press conference. Sales will initially be limited to 10 ART kits per person to ensure that there are "adequate supplies for all”, said the Health Ministry's director of medical services Kenneth Mak. But as more supplies are made available for retail sales, authorities will "eventually allow test kits to be freely purchased", he said. Prof Mak said: "The ART self-test kits complement our overall surveillance strategy. "These fast and easy-to-use tests allow us to detect infected cases more quickly, in particular among individuals who do not have acute respiratory infection symptoms, but are concerned that they may have been exposed to Covid-19." This might be for people who had been to a place that a confirmed case had visited, for instance. The four self-test kits that have been granted interim authorisation by the Health Sciences Authority (HSA) for sale to the public are the Abbott PanBio Covid-19 Antigen Self-Test, the Quidel QuickVue At-Home OTC Covid-19 Test, the SD Biosensor Sars-CoV-2 Antigen Self-Test Nasal, and the SD Biosensor Standard Q Covid-19 Ag Home Test. In response to media queries, Watsons Singapore said it will be retailing the Abbott and Quidel QuickVue test kits at all pharmacy stores in phase one of the test kit roll-out. "We would be keeping with MOH’s recommended guidelines on retail selling price, which will range from approximately $10 to $13 per test kit," it said. MOH said: "Individuals who have a positive result for their ART self-test should immediately approach a Swab And Send Home public health preparedness clinic for a confirmatory polymerase chain reaction (PCR) test. "They are then required to self-isolate until they receive a negative PCR test result." Meanwhile, those who test negative on their self-test ART should still stay vigilant and adhere to prevailing safe management measures, MOH said.
  19. Lockdown announce liao wor.. 1 june onwards PETALING JAYA: A nationwide full lockdown, similar to the first movement control order in March last year, will be in place from June 1 to 14. Except for essential economic and service sectors, all other sectors will not be allowed to operate during this period. A special National Security Council meeting chaired by the Prime Minister on Friday (May 28) made the decision to implement 14-day full lockdown. https://www.thestar.com.my/news/nation/2021/05/28/covid-19-nsc-decides-nationwide-lockdown-from-june-1-to-14
  20. https://en.wikipedia.org/wiki/Darwinism Darwinism is a theory of biological evolution developed by the English naturalist Charles Darwin (1809–1882) and others, stating that all species of organisms arise and develop through the natural selection of small, inherited variations that increase the individual's ability to compete, survive, and reproduce. https://www.straitstimes.com/business/companies-markets/ministry-of-food-winding-up-fails-to-pay-debt-of-200000 Ministry of Food winding up, fails to pay debt of $200,000 SINGAPORE - Home-grown restaurant chain Ministry of Food is winding up after failing to pay a debt of $200,000. We all know Charles Darwin so I'm not going to explain his theory of natural selection. Nevertheless, I created this thread because it's pretty amazing we're 1 year plus into the pandemic and there are businesses/individuals that still refuses to evolve. They continue to think the world will return to normal and rely on government aid (tax payers money) or cheap labor (maximize margin) to drive their organizations (plus complain a lot). Do you think they are worth saving?
  21. BANGKOK (BLOOMBERG) - Thailand, already facing its worst coronavirus outbreak since the start of the pandemic, is considering cutting its prison population by as much as 16 per cent to counter the rapid spread of infections among inmates and workers in overcrowded facilities. More than 10,000 new Covid-19 cases have been reported in about a dozen densely packed Thai prisons. These latest clusters have pushed the country's daily case count to record highs twice in the past week, including on Monday (May 17) when more than two-thirds of the 9,635 infections were reported in prisons, official data showed. The outbreak in the correctional system reflects conditions in many parts of metropolitan Bangkok, where infections have spread quickly in dense slums, crowded construction sites and even a government-housing complex. The slow rate of vaccinations has added to the challenge facing the authorities. "If we can't get enough vaccines or if we can't contain the spread quickly, we'll have to think about reducing the number of inmates in the system through early release," according to Justice Minister Somsak Thepsuthin. "They're already incarcerated. They shouldn't have to suffer more than that." With about 311,000 inmates, Thai prisons are running at 5 per cent above official capacity. More than 80 per cent of those incarcerated face charges for narcotics violations. The Justice Ministry is looking at a special early-release programme for about 50,000 inmates, that could include the use of electronic-monitoring systems and adjustment of criteria. However, Mr Somsak said that the ministry's current priority is to administer vaccines to inmates and correctional officers to cut infections. In the longer term, Thailand's drug laws will be changed to allow shorter jail sentences for minor offences and to focus more on rehabilitation, which will reduce overcrowding and costs, he said. if anyone recall the news a few years ago... thailands prison conditions damn atrocious 2019 jail conditions....................... if the 2021 jail condition is not any better then........................................ https://mothership.sg/2019/12/thailand-prison-video-leak/
  22. TAIPEI (REUTERS) - Taiwan raised its Covid-19 alert level on Saturday (May 15) for the capital, Taipei, and New Taipei City, ushering in a two-week clampdown on gatherings as well as the closure of many venues, while announcing 180 new domestic infections. Separately, major universities in northern Taiwan are shifting to online learning and some museums will shut as the island grapples with a rare spike in domestic Covid-19 infections, taking urgent measures to stop the spread. The new rules will not mean offices, schools or restaurants have to close, but will cause the shutdown of cinemas and other entertainment spots, while limiting family get-togethers to five people indoors and 10 outdoors. Taipei’s government has already ordered bars, nightclubs and similar venues to shut. Since the pandemic began, Taiwan has reported fewer than 1,500 cases among a population of about 24 million, most of them imported from abroad, but a recent rise in community transmissions has spooked residents. The island has never gone into a full lockdown and its people are used to life carrying on near normal, despite the pandemic ranging in many other parts of the world. Although Taiwan has just 1,290 cases, most of them imported from abroad, among a population of about 24 million, a recent small rise in community transmissions has spooked residents used to life carrying on as normal, despite the global pandemic. Late on Friday, several universities, including the elite National Taiwan University, said they would immediately switch to remote learning, telling students to stay away from campuses. "As Covid-19 is still wreaking havoc, please be reminded to wear a mask at all times when you go out, wash hands frequently, and keep appropriate social distancing," National Taiwan University said in a statement. The Taipei Fine Arts Museum, where people have queued for a hugely popular exhibition by Japanese artist Shiota Chiharu opened this month, said it would close from Saturday to comply with the city's prevention rules. "The re-opening date will be announced according to the epidemic situation and city regulations," it said. Taipei's National Palace Museum, home to one of the world's best and most extensive collections of Chinese art, said it too would close from Saturday. The current cluster of infections has centred on the north and Taipei, but cases have also cropped up elsewhere, such as the major southern port city of Kaohsiung. Its mayor, Chen Chi-mai, said authorities would disinfect wide range of public spaces, including the night markets that are usually a big draw for hungry tourists. https://www.straitstimes.com/asia/east-asia/taiwan-universities-shift-online-museums-shut-in-battle-with-covid-19
  23. https://www.channelnewsasia.com/news/singapore/covid-19-jewel-changi-airport-terminals-1-3-closed-public-14795582
×
×
  • Create New...